Matches in SemOpenAlex for { <https://semopenalex.org/work/W2418447989> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- W2418447989 endingPage "50" @default.
- W2418447989 startingPage "247" @default.
- W2418447989 abstract "This study sought to evaluate the safety and feasibility of using the combination of aspirin, front-loaded clopidogrel, enoxaparin, and eptifibatide in patients with acute coronary syndromes immediately prior to percutaneous coronary intervention. One hundred ninety-eight patients (39 with acute myocardial infarction) received aspirin 325 mg orally, clopidogrel 300 mg orally, enoxaparin 0.5 mg/kg intravenous (IV), and eptifibatide using the ESPIRIT dosing (180 g/kg bolus IV, immediately followed by a 2 g/kg/minute continuous IV infusion, and then a second 180 g/kg bolus IV ten minutes after the first bolus). A total of 363 lesions were intervened; two were determined unsuccessful. Arterial sheaths were removed using manual compression after 3 hours. In the immediate follow-up, one patient developed rigors thought to be related to the eptifibatide therapy and a second patient experienced rebleeding at the access site. No other major bleeding or access-site hematomas were noted, and no patient developed thrombocytopenia. Over the subsequent 30 days, no episodes of acute vessel/stent thromboses were recognized. There were no deaths. Repeat coronary intervention was required in one patient at a previously untreated site. Clopidogrel was discontinued early in 5 patients due to rash. In conclusion, this pilot study demonstrates the feasibility of administering aspirin, clopidogrel, enoxaparin, and eptifibatide in the setting of percutaneous coronary intervention for acute coronary syndromes. These agents can be administered moments before the coronary intervention with no apparent compromise in patient safety." @default.
- W2418447989 created "2016-06-24" @default.
- W2418447989 creator A5011403969 @default.
- W2418447989 creator A5024458421 @default.
- W2418447989 creator A5063820919 @default.
- W2418447989 date "2002-05-01" @default.
- W2418447989 modified "2023-10-14" @default.
- W2418447989 title "Use of clopidogrel loading, enoxaparin, and double-bolus eptifibatide in the setting of early percutaneous coronary intervention for acute coronary syndromes." @default.
- W2418447989 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11983945" @default.
- W2418447989 hasPublicationYear "2002" @default.
- W2418447989 type Work @default.
- W2418447989 sameAs 2418447989 @default.
- W2418447989 citedByCount "4" @default.
- W2418447989 crossrefType "journal-article" @default.
- W2418447989 hasAuthorship W2418447989A5011403969 @default.
- W2418447989 hasAuthorship W2418447989A5024458421 @default.
- W2418447989 hasAuthorship W2418447989A5063820919 @default.
- W2418447989 hasConcept C126322002 @default.
- W2418447989 hasConcept C141071460 @default.
- W2418447989 hasConcept C164705383 @default.
- W2418447989 hasConcept C2777628954 @default.
- W2418447989 hasConcept C2777698277 @default.
- W2418447989 hasConcept C2777849778 @default.
- W2418447989 hasConcept C2778283817 @default.
- W2418447989 hasConcept C2778583881 @default.
- W2418447989 hasConcept C2780400711 @default.
- W2418447989 hasConcept C2780911114 @default.
- W2418447989 hasConcept C2781056559 @default.
- W2418447989 hasConcept C35294091 @default.
- W2418447989 hasConcept C42219234 @default.
- W2418447989 hasConcept C43376680 @default.
- W2418447989 hasConcept C500558357 @default.
- W2418447989 hasConcept C71924100 @default.
- W2418447989 hasConceptScore W2418447989C126322002 @default.
- W2418447989 hasConceptScore W2418447989C141071460 @default.
- W2418447989 hasConceptScore W2418447989C164705383 @default.
- W2418447989 hasConceptScore W2418447989C2777628954 @default.
- W2418447989 hasConceptScore W2418447989C2777698277 @default.
- W2418447989 hasConceptScore W2418447989C2777849778 @default.
- W2418447989 hasConceptScore W2418447989C2778283817 @default.
- W2418447989 hasConceptScore W2418447989C2778583881 @default.
- W2418447989 hasConceptScore W2418447989C2780400711 @default.
- W2418447989 hasConceptScore W2418447989C2780911114 @default.
- W2418447989 hasConceptScore W2418447989C2781056559 @default.
- W2418447989 hasConceptScore W2418447989C35294091 @default.
- W2418447989 hasConceptScore W2418447989C42219234 @default.
- W2418447989 hasConceptScore W2418447989C43376680 @default.
- W2418447989 hasConceptScore W2418447989C500558357 @default.
- W2418447989 hasConceptScore W2418447989C71924100 @default.
- W2418447989 hasIssue "5" @default.
- W2418447989 hasLocation W24184479891 @default.
- W2418447989 hasOpenAccess W2418447989 @default.
- W2418447989 hasPrimaryLocation W24184479891 @default.
- W2418447989 hasRelatedWork W1594634064 @default.
- W2418447989 hasRelatedWork W1974655135 @default.
- W2418447989 hasRelatedWork W2077361797 @default.
- W2418447989 hasRelatedWork W2216304565 @default.
- W2418447989 hasRelatedWork W2418447989 @default.
- W2418447989 hasRelatedWork W2434973174 @default.
- W2418447989 hasRelatedWork W2588315230 @default.
- W2418447989 hasRelatedWork W2990078646 @default.
- W2418447989 hasRelatedWork W3033264199 @default.
- W2418447989 hasRelatedWork W45326695 @default.
- W2418447989 hasVolume "14" @default.
- W2418447989 isParatext "false" @default.
- W2418447989 isRetracted "false" @default.
- W2418447989 magId "2418447989" @default.
- W2418447989 workType "article" @default.